Predicting the cytotoxicity of disinfection by-products to Chinese hamster ovary by using linear quantitative

Li-Tang Qin1,2,3, Xin Zhang1, Yu-Han Chen1

  • 1College of Environmental Science and Engineering, Guilin University of Technology, Guilin, 541004, China.

Insights

Predicting disinfection by-product (DBP) toxicity is crucial. This study developed reliable linear quantitative structure-activity relationship (QSAR) models to accurately forecast the cytotoxicity of emerging DBPs to Chinese hamster ovary (CHO) cells.

Area of Science:

  • Environmental Chemistry
  • Toxicology
  • Computational Chemistry

Background:

  • Disinfection by-products (DBPs) are emerging contaminants with potential health risks.
  • Accurate prediction of DBP toxicity is essential for risk assessment and management.
  • Existing models for DBP toxicity prediction require further development and validation.

Purpose of the Study:

  • To establish a reliable quantitative structure-activity relationship (QSAR) model for predicting the cytotoxicity of disinfection by-products (DBPs).
  • To assess the predictive performance of linear QSAR models using Chinese hamster ovary (CHO) cell data.
  • To ensure the developed models have wide applicability domains for diverse DBPs.

Main Methods:

  • Collected cytotoxicity data for 74 DBPs using Chinese hamster ovary (CHO) cells as the endpoint.
  • Developed linear QSAR models utilizing multiple linear regression (MLR) analysis.
  • Validated the models through internal (LOOCV, LMOOCV, bootstrapping) and external validation techniques.

Main Results:

  • The developed MLR-based QSAR models demonstrated high goodness of fit (R² = 0.763-0.799).
  • Models exhibited excellent robustness (Q²LOO = 0.718-0.745) and predictive ability (CCC = 0.806-0.848).
  • Williams plot analysis confirmed the models' wide application domains and coverage of 74 structurally diverse DBPs.

Conclusions:

  • Linear QSAR models provide a reliable approach for predicting the cytotoxicity of disinfection by-products (DBPs) to Chinese hamster ovary (CHO) cells.
  • The developed models are robust and possess strong predictive capabilities for a wide range of DBPs.
  • These QSAR models can aid in the risk assessment of emerging DBPs in water treatment and environmental monitoring.

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Local Anesthetics: Chemistry and Structure-Activity Relationship01:30

Local Anesthetics: Chemistry and Structure-Activity Relationship

Local anesthetics (LAs) are drugs that induce a temporary loss of sensation in a limited body area, preventing pain. Cocaine was the first local anesthetic discovered in the late 19th century. Cocaine is a benzoic acid ester obtained from the leaves of coca shrubs and was often used for its psychotropic effects. Cocaine was first isolated in 1860 by Albert Niemann. Sigmund Freud studied the physiological actions of cocaine. Carl Koller later introduced it into clinical practice in 1884 as a...
6.5K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship01:29

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.7K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.9K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
942
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
2.1K